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Abstract
OBJECTIVE: The objective if this systematic review is to determine whether or not cardiac
resynchronization therapy with aerobic exercise improves exercise tolerance / ability better then either
treatment alone or no intervention at all.

STUDY DESIGN: Review of 4 English language primary studies. 2 Investigator Blinded and 2 Double
Blind Crossover studies were used.

DATA SOURCES: Articles were found utilizing OVID and COCHRANE databases.

OUTCOME MEASURED: 4 outcomes were considered in this review. Dyspnea, leg comfort, exercise
time / AT, and V02 (exercise tolerance).

RESULTS: The Wasserman article concludes that those indivduals who are beginning with a baseline
Peak V02 of < 50% of predicted benefit greatly from BVP-ON w/exercise while those with BVP-OFF
or BVP-ON (Peak V02 > 50% predicted) show no statistically significant different. The Laveneziana
article concludes patients with CRT-ON during exercise showed marked improvement in dyspnea and
leg discomfort (typically leg discomfort is seen as the major limiting symptom in patients with CHF [as
seen in this study]). The Schlosshan article concludes that CRT in long term therapy (post remodeling)
continues to confer benefit to the heart. The Conraads article concludes that the combination of CRT
with endurance training show a synergistic effect on exercise tolerance (better then either alone).

CONCLUSION: The results of all 4 articles express similar conclusion. Exercise and CRT therapy are
both beneficial on exercise tolerance and perhaps even reduction of cardiac remodeling. However,
Exercise with CRT therapy provides benefit beyond either therapy alone.

KEY WORDS: CRT (cardiac resynchronization therapy), LVEF (left ventricular ejection fraction),
peak VO2, NYHA (new york heart association), BVP (bi-ventricular pacing), CHF (congestive heart
failure), CPET (cardiopulmonary exercise testing), LVF (left ventricular failure), AT (anaerobic
threshold).

INTRODUCTION
Congestive heart failure is a condition where the heart is no long able to pump an adequate
amount of blood throughout the body. It affects millions of people world wide. CHF is more prevelant
with age which makes it an increasingly important issue as our aged population continues to enlarge.
There are many causes such as coronary artery disease, HTN or any condition that alters / damages
heart tissue (MI, viruses, toxic exposures). There are different types of heart failure: systolic
dysfunction, diastolic dysfunction. Systolic function involves impairment in heart contraction such as
in a dilated cardiomyopathy. Diastolic dysfunction involves impairment in ventricle filling such as in a
ventricular hypertrophy. CHF can be classified according to symptoms experienced during everyday
activities using the New York Heart Association classification.
Table 1: NYHA Classifications
NYHA Class
I

II

III

IV

Symptoms
No symptoms and no limitation in ordinary
physical activity, e.g. shortness of breath
when walking, climbing stairs etc.
Mild symptoms (mild shortness of breath
and/or angina) and slight limitation during
ordinary activity.
Marked limitation in activity due to symptoms,
even during less-than-ordinary activity, e.g.
walking short distances (20–100 m).
Comfortable only at rest.
Severe limitations. Experiences symptoms
even while at rest. Mostly bedbound patients.

There are many signs and symptoms of congestive heart failure. There are non side specific
symptoms such as tachycardia, hypotension, diaphoresis, cachexia, cyanosis, clubbing. There are left
sided heart failure signs and symptoms such as shortness of breath, orthopnea, chronic non-productive
cough and exercise intolerance. There are right sided heart failure signs and symptoms such as loss of
appetite, (pitting) edema, ascites, nausea, jugular venus pressure increse, hepatic enlargment. It is
important to remember that most patients suffer a combination of both left and right sided heart failure
with one predominating. Right sided heart failure is most commonly caused by left sided heart failure.

Diagnoses can be made by analyzing multiple areas of health: CBC, renal function tests, BNP,
EKG, chest radiography, echo cardiography , angiography and cardiac catheterization. While there are
multiple avenues for diagnosing; effective treatments / cures still elude us. There are a multitude of
both pharmacological and non-pharmacological treatments. The current standard medicines are
diuretics, ACE inhibitors, ARB's, beta blockers, digitalis, nitrates, neseritide and hydralazine. Other
pharmacological treatments include inotropic agents, antiarhythmics, statins, anticoagulation and
CCB's. Non-pharmacological treatments involve revascularization, cardiac transplant, diet, exercise
and pacing. Exercise and ventricular pacing our the focus of this paper. The importance of research and
evidence based treatments can be seen in the sequelae of congestive heart failure: organ failure (kidney
/ liver), pulmonary edema, decrease in physical capacity and death.
Physician assistants are highly valued instruments in the care of CHF patients. CHF is a nonreversible disease that requires enormous amounts of care and money. PA's, rather then doctors, are
able to spend longer periods of time with patients aiding them in understanding their disease and
employing treatments that are best suited to them at a lower cost. The treatments highlighted in this
paper are time consuming and require discipline, however as you will see in this paper are effective.
OBJECTIVE
The objective if this systematic review is to determine whether or not cardiac resynchronization
therapy with aerobic exercise improves exercise tolerance / ability better then either treatment alone or
no intervention at all. The hypothesis is that the above two treatments do indeed improve exercise
tolerance better then either treatment alone or not at all.
METHODS
All 4 studies met the following criteria for population selection. Patients were aged 50-80 with a
NYHA class II or greater. Left ventricular ejection fraction (LVEF) was < 35% in all selected patients
and the QRS complex width was > 120ms. Two of the studies were investigator blinded [Wasserman,
Conraads] and 2 of the studies were double blind crossover studies [Laveneziana. Schlosshan]

The general interventions were CRT on or off during aerobic exercise. Essentially pts with CRT
on during exercise were compared to patients with CRT off during exercise. In one experiment CRT
with exercise is compared to CRT alone [Conraads]. Four questions were analyzed to determine
treatment outcome. Do patients feel exercise tolerance is improved? Do patients experience less
dyspnea? Do patients experence less leg pain? Peak oxygen uptake was also used as a way to measure
exercise tolerance.
The 1st study [Wasserman] was conducted throughout the United States at many different
facilities. Every site abided by a workout protocol on either a bike or a treadmill. Baseline and 6 month
protocols were the same. The 2nd study [Conraads] is a European study that utilized a rigorous
endurance training protocol for the CRT with ET and not training protocol for CRT without ET. There
were baseline and 5 month measurements in this study. The 3rd study [Schlosshan] is a crossover study
conducted in Europe. Patients were evaluated with CRT either on or off and then on a separate day
evaluated again with their CRT setting changed to the opposite setting. The 4th study [Lavenezia] is a
crossover study conducted in Canada. This study was a three days study with the first day being part of
the learning curve and days 2 – 3 generating the results. Pt's were randomized to CRT on or off and
switched the next day to the opposite setting. Pt were tested under incremental cycle exercising.
Key words used in searches were: CRT (cardiac resynchronization therapy), LVEF (left
ventricular ejection fraction), peak VO2, NYHA (new york heart association), BVP (bi-ventricular
pacing), CHF (congestive heart failure), CPET (cardiopulmonary exercise testing), LVF (left
ventricular failure), AT (anaerobic threshold). All articles were published in peer review journals in
English. Articles were found using Ovid and Cochrane databases and were chosen based on relevant
and patient oriented evidence. Articles included were from 2007 or later due to a pending review in
2006. All articles were RCTs and investigator blinded.

Table 2: Demographics
Study

Type

#Pts

Age (yrs) Inclusion
Criteria

Exclusion
Criteria

W/D

Interventio
ns

0 (18
crossed
over from
BVP-OFF
to BVP-ON

Randomize
d to BVPON or BVP
OFF

Wasserman Investigato 239
, USA,
r Blinded
2007
RCT

60-80

NYHA Class II- NYHA class I
IV LVF pts with with narrow
wide (>120ms) QRS complex
QRS complexes
and w/o BVP

Conraads,
Europe,
2007

50-68

Ischaemic or
dilated
cardiomyopathy
; NYHA > III;
LVEF < 35%;
LVEDD >
55mm; LBBB >
120ms;
permanent sinus
rhythm

< 1 month
0
stable
pharmacologi
cal drug
treatment;
minimal
interventricular
dyssynchrony

Randomize
d to CRT
(+)
[w/exercise
training] or
CRT (-)
[w/o
exercise
training]

Schlosshan Randomize 15
, Europe,
d Double
2009
Blind
Crossover
Trial

54 - 72

Before CRT:
NYHA > III,
QRS > 120,
LVEF < 35%
After CRT:
NYHA I – III (ie
symptomatic
benefit from
CRT)

Inability to do 0
treadmill,
exercise
beyond
anaerobic
threshold,
angina,
coexisting
lung, other
systemic
diseases

CRT ON or
OFF (order
pt did the
test on or
off was
blinding
since it was
a
crossover)

Lavenezian Randomize 7
a, Europe, d Double
2009
Blind
Crossover
Trial

69-73

CRT > 6m;
NYHA III – IV;
LVEF < 35%;
QRS > 120ms

Major
0
cardiovascula
r event in
previous 6w,
HF needing
continuous IV
TX, resting
O2 < 90% or
4% decrease
during
exercise,
other illness /
inability to
perform
exercise

CRT ON or
OFF (order
pt did the
test on or
off was
blinding
since it was
a
crossover)

Investigato 17
r Blinded
RCT

OUTCOMES MEASURED
The key outcome measured in 3 / 4 studies [Laveneziana excluded] was V02 (peak oxygen
uptake). Peak oxygen uptake measures the patients maximum capacity to use and transport oxygen
exercise. This measurement translates into the individuals physical fitness level. Another primary
outcome [included by Wasserman, Schlosshan] was anaerobic threshold. Anaerobic threshold marks
exercise that is rigorous enough to trigger anaerobic metabolism. Both V02 and AT are essentiall
POEMs (patient oriented evidence that matters) in that improving values for both indicate the pt is able
to exercise longer and harder without pain or fatigue.
[Laveneziana] utilized dyspnea and pain ratings to characterize the effects of exercise and CRT
therapy. Pain was rated using the Borg scale. Other secondary measurements included heart rate,
ventilation ratio and exercise time. The importance of all these measurements is that they can all show
in both a subjective and physiologic way the patients exercise tolerance.
RESULTS
Three of the four studies were convertible into dichotomous data [except Conraads]. The study
data were compiled with intention-to-treat analysis in all four studies. All patients who began the study
finished it.
Wasserman et al reported a 28% risk reduction when CRT was turned on (with a number need to
treat of 4). The p-value was 0.0001 with a paired t test. The relative risk reduction could not be
measured since the CER was 0.
Laveneziana et al reported that both leg discomfort and dyspnea were higher in the CRT off
group. The p-value was 0.05. RRR and ARR could not be calculated in this study. Data shows an
average dypsnea / pain rating (borg units) for CRT-OFF and CRT-ON but does not specify an n value.
Pts were repeatedly used but randomized as to whether thy were receiving CRT for each exercise
session.

Schlosshan et al showed that CRT-on during exercise led to an 8% improvement in exercise
time and a 9% improvement in aerobic capacity. The p-value was 0.04 and 0.01 respectively. RRR and
ARR could not be calculated in this study. The results show data averages +- deviations.
Conraads et al showed the CRT therapy plus exercise translated to a synergistic effect on V02
increase. The p-value was 0.00003. Breath-by-breath gas exchange measurements were performed
using a metabolic cart. Ventilation (VE) oxygen uptake (V02) and carbon dioxide production VC02)
were determined on-line every 15s resulting in continuous data that could not be transformed into
dichotomous data.
Table 3: Dichotomous Results
Study

CER

EER

RBI

ABI

NNT

P Value

Wasserman

0.00%

28.00%

NA

28.00%

~4

0.0001

Table 3 shows the results of calculations to determine benefit increases. Of the results, only one
area of data was significantly significant. Only that data was included in the calculation. 54 of 192
individuals who were evaluated with CRT on showed a statistically significant improvement in their
peak VO2. Those 54 individuals started with a baseline VO2 of < 50% expected. There was no
statistically significant data in the CRT off group resulting in n=0 for those with improved VO2.
Consequently, the relative benefit increase cannot be calcuated due to a CER of 0. Likewise the
anaerobic threshold improved in 40% of those with CRT on (p-value 0.0001) and could not be
evaluated in CRT off due to a lack of statistical significance (study records 28% of persons improved).
Table 4: Lavenezia Results
POEM

CRT On

CRT Off

Dyspnea

2.7 +- 0.9*

4.6 +- 1.2

Leg Discomfort

4.7 +- 1.1*

6.7 +- 0.7

* P < 0.05
Table 4 shows the POEM results of the lavenezia et al study. Utilizing the Borg scale (0 no
breathlessness – 10 max breathlessness) pt rated their dyspnea and leg discomfort while at rest, each

minute of exercise and at peak exercise. A trend that can be noticed is CRT on values are often
associated with statistical significance while CRT off values are not. Table 4 shows this trend. Both
CRT on result in lower borg scale ratings (ie less dyspnea and leg discomfort) then CRT off. Lavenezia
et al also measured value shared by the other studies such as VO2, pulse, etc... The results of these
other parameters show general improvement when CRT was set to on.
Table 5: Schlosshan Results
POEM

CRT On

CRT Off

P Value

VO2

17.2 +- 4.9

15.6 +- 4.3

0.005

Exercise Time

587 +- 212

542 +- 204

0.04

Table 5 shows the results of the Schlosshan et al study. Both V02 and exercise time were
statisticall significant and showed improvement in those who had CRT set to on. Because this was a
crossover study there were no n values assigned. Like the other studies, there were multiple parameters
measured, however VO2 and exercise time are the most compatible when using as comparison to the
other studies.
The Conraads et al study compared 4 groups of individuals to compare CRT with exercise and
pharmacology, CRT with pharmacology, exercise and pharmacology and pharmacology alone. The
study shows that the combination of CRT, exercise and pharmacology together resulted in the best
outcome when measuring V02. CRT with pharmacology and pharmacology with exercise were similar
in result. Pharmacology alone proved to be the least effective treatment protocol. VO2 measured at
baseline and post the endurance training timeline.
The number needed to harm has not been calculated in this paper for the reason that we are
examining the synergistic effects of exercise when combined CRT therapy. Both therapies are
inherently safe (aside from the complications of the implanting the pacer) are not known for causing
harm. The purpose of this paper was to emphasize the clinical importance of utilizing both therapies

when treating heart failure patients.
DISCUSSION
There are many therapies for heart failure, however there is a lack of evidence for definitive
treatments aside from cardiac transplant. Therapies aim to accomplish two big task in the heart failure
patient: prevent remodelling of the heart, improve ADLs. While we have taken a closer look at the pt's
ADLs (ie POEMs) its important to remember that the studies do mention there appears to be
improvement in the prevention of remodeling, though more studies are needed. CRT therapy aids the
CHF patient by synchronizing the ventricles to work together providing stronger and more efficient
contractions. Increased efficiency translates to better oxygenation throughout the body and therefore
less cardiac demand. The results in less stress by the heart and a reduction in remodeling. Exercise in a
normal healthy individual improves all of the different parameters we have studies in this paper such as
VO2, exercise time, etc... With CRT therapy, even a heart failure pt can gain the full effects of exercise
that a healthy heart can.
There are limitations to this review. The parameters between utilized RCTs vary, however they
all point to the same generalized concept of exercise ability. Unfortunately evidence must be repeatable
and better conclusions could be drawn with RCTs operating under the same study design. Population
size was another limitation to the studies. For example [Conraads] represented 17 individuals. The
results perhaps would have more statistical significance given a bigger set of individuals. CRT on is
often statistically significant in the studies whereas CRT off is not. Consequently CRT off is usally the
smaller subset such as in [Wasserman] where 192 were set to CRT on and 47 to CRT off. The condition
of the pt entering the study may also play a role in how much of an impact the therapies have to offer.
For example [Wasserman] deduces that those with a baseline V02 < 50% of the expected value seemed
to benefit the most from the therapies. In future studies it might be beneficial to categorize the pts with
a little more rigger rather then just NYHA classifications. [Conraads] pointed out that their study may
have suffered from bias since they utilized data from a different trial and evaluated it while looking at a

different variable.
CONCLUSION
Cardiac resynchronization therapy and aerobic exercise does improve exercise tolerance /
ability in heart failure patients better then either intervention alone. More study is needed to evaluate
the best exercise regimen for the heart failure pt and also which type of heart failure patients benefit the
most from a combination CRT / exercise regimen.
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